Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI.

Contrast Media Mol Imaging

Axe Métabolisme, santé vasculaire et rénale, Centre hospitalier universitaire de Québec, 10 rue de l'Espinay Québec, Canada G1L 3L5.

Published: January 2012

The majority of contrast agents used in magnetic resonance imaging (MRI) is based on the rare-earth element gadolinium. Gadolinium-based nanoparticles could find promising applications in pre-clinical diagnostic procedures of certain types of cancer, such as glioblastoma multiforme. This is one of the most malignant, lethal and poorly accessible forms of cancer. Recent advances in colloidal nanocrystal synthesis have led to the development of ultra-small crystals of gadolinium oxide (US-Gd(2)O(3), 2-3 nm diameter). As of today, this is the smallest and the densest of all Gd-containing nanoparticles. Cancer cells labeled with a sufficient quantity of this compound appear bright in T(1)-weighted MRI images. Here we demonstrate that US-Gd(2)O(3) can be used to label GL-261 glioblastoma multiforme cells, followed by localization and visualization in vivo using MRI. Very high amounts of Gd are efficiently internalized and retained in cells, as confirmed with TEM and ICP-MS. Labeled cells were visualized in vivo at 1.5 T using the chicken embryo model. This is one more step toward the development of "positively contrasted" cell tracking procedures with MRI.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cmmi.420DOI Listing

Publication Analysis

Top Keywords

gadolinium oxide
8
cancer cells
8
vivo mri
8
glioblastoma multiforme
8
cells
5
mri
5
ultra-small gadolinium
4
oxide nanoparticles
4
nanoparticles image
4
image brain
4

Similar Publications

Biomedical Application Prospects of Gadolinium Oxide Nanoparticles for Regenerative Medicine.

Pharmaceutics

December 2024

Department of Hospital Surgery, Department of Plastic and Reconstructive Surgery, Cosmetology and Cell Technology, Pirogov Russian National Research Medical University (RNRMU), 117997 Moscow, Russia.

Background/objectives: The aim was to study the possibilities of biomedical application of gadolinium oxide nanoparticles (GdO NPs) synthesized under industrial conditions, and evaluate their physicochemical properties, redox activity, biological activity, and safety using different human cell lines.

Methods: The powder of GdO NPs was obtained by a process of thermal decomposition of gadolinium carbonate precipitated from nitrate solution, and was studied using transmission electron microscopy (TEM), X-ray diffraction (XRD), Raman spectroscopy, mass spectrometry, and scanning electron microscopy (SEM) with energy dispersive X-ray analyzer (EDX). The redox activity of different concentrations of GdO NPs was studied by the optical spectroscopy (OS) method in the photochemical degradation process of methylene blue dye upon irradiation with an optical source.

View Article and Find Full Text PDF

Orthotopic tumor models in pre-clinical translational research are becoming increasingly popular, raising the demands on accurate tumor localization prior to irradiation. This task remains challenging both in X-ray and proton computed tomography (xCT and pCT, respectively), due to the limited contrast of tumor tissue compared to the surrounding tissue. We investigate the feasibility of gadolinium oxide nanoparticles as multimodal contrast enhancement agent for both imaging modalities.

View Article and Find Full Text PDF

Triggered by the vulnerability to atherosclerotic plaques, cardiovascular diseases (CVDs) have become a main reason for high mortality worldwide. Thus, there is an urgent need to develop functional molecular imaging modalities to improve the detection rate of vulnerable plaques. In this study, polyethyleneimine (PEI) was coated on the surface of mesoporous silica nanoprobes (MSN) loaded with GdO (MSN@GdO), followed by coupling the fluorescent dye carboxylated heptamethine cyanine (IR808), and then the dextran sulfate (DS) was modified on the surface of MSN@GdO@IR808 by electrostatic adsorption, to construct a targeted and pH-responsive magnetic resonance (MR)/near-infrared fluorescence imaging (NIRF) dual-modal nanoprobe (MSN@GdO@IR808@DS nanoparticles).

View Article and Find Full Text PDF
Article Synopsis
  • - The development of a new optical temperature sensing nanoprobe combines rare-earth-doped gadolinium oxide nanocrystals with mesoporous silica-coated gold nanorods to enhance tumor treatment by allowing real-time tissue temperature monitoring.
  • - This nanoprobe shows a significant increase in near-infrared photoluminescence when exposed to 980 nm irradiation, enhancing sensitivity for temperature changes, which is crucial for minimizing damage to healthy tissues during therapy.
  • - With its impressive temperature sensitivity of 7.25% K at 338 K and improved optical performance due to surface plasmon resonance, the nanoprobe holds great promise for advancing photothermal therapy techniques.
View Article and Find Full Text PDF

The current study aims to introduce a new polymeric composite consisting of epoxy resin as the matrix and gadolinium oxide (GdO) as the neutron adsorption ingredient. The shielding performance of the composite was assessed by neutron attenuation experiments with an Am-Be source and polyethylene moderator. The results of these experiments showed an appreciable agreement with the Monte Carlo simulations.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!